Filter
Top Products
M3860A/M3861A HEARTSTART FR2+
1-2
Philips Medical Systems
When Is the HeartStart FR2+ Used?
The HeartStart FR2+ Defibrillator is used with disposable defibrillator pads
applied to a person who is experiencing the symptoms of sudden cardiac
arrest (SCA): lack of responsiveness and lack of breathing. Defibrillation
should not be performed on anyone who is responsive or is breathing.
Infant/child reduced-energy defibrillator pads are available for use with the
FR2+ on children under the age of 8 or weighing less than 55 pounds (25
kg).
The FR2+ is intended for use by emergency care personnel who have been
specifically trained in the operation of the FR2+ or who are qualified by
training in Basic Life Support (BLS), in Advanced Life Support (ALS), or in
other physician-authorized emergency medical response.
At the discretion of emergency care personnel, the M3860A FR2+ with
ECG display enabled can also be used with the FR2+ ECG assessment
module to display the rhythm of a responsive or breathing patient, regardless
of age. The FR2+ Defibrillator used with the FR2+ ECG assessment module
provides a non-diagnostic display for attended patient monitoring. While
connected to the FR2+ ECG assessment module, the FR2+ displays and
evaluates the patient's ECG and disables its shock capability.
How Does the HeartStart FR2+ Work?
The HeartStart FR2+ Defibrillator is designed to provide external
defibrillation therapy to someone in cardiac arrest. Defibrillation therapy is
the best available way to treat a variety of potentially fatal heart arrhythmias.
The FR2+ is extremely easy to use. When connected to defibrillator pads
that are properly applied to the patient’s bare chest, the FR2+:
1. prompts you to take specific actions,
2. automatically analyzes the patient's heart rhythm and advises you
whether or not the rhythm is shockable, and
3. arms the Shock button, if appropriate, and instructs you to press it to
deliver a biphasic electric pulse designed to defibrillate the heart.
Detailed instructions for use are provided in Chapter 3.